ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
-0,05%
Bitcoin
66.166,27
0,24%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. Hls Therapeutics (HLS)

  7. Hls Therapeutics (HLS) News

HLS

Hls Therapeutics (HLS)

Hls Therapeutics
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:HLS
DatumZeitQuelleÜberschriftSymbolFirma
19/02/201912h30PR Newswire (Canada)HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceTSXV:HLSHls Therapeutics
06/02/201912h30PR Newswire (Canada)HLS Therapeutics Announces Graduation to the Toronto Stock ExchangeTSXV:HLSHls Therapeutics
29/01/201912h30PR Newswire (Canada)HLS Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock ExchangeTSXV:HLSHls Therapeutics
15/11/201812h30PR Newswire (Canada)HLS Therapeutics Announces Q3 2018 Financial ResultsTSXV:HLSHls Therapeutics
12/11/201812h30PR Newswire (Canada)HLS Therapeutics Announces that Amarin's Vascepa ® (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite E...TSXV:HLSHls Therapeutics
01/11/201811h30PR Newswire (Canada)HLS Therapeutics to Host 2018 Third Quarter Results Conference CallTSXV:HLSHls Therapeutics
24/09/201811h30PR Newswire (Canada)HLS Therapeutics Announces that Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules M...TSXV:HLSHls Therapeutics
06/09/201812h30PR Newswire (Canada)HLS Therapeutics Appoints Tim Hendrickson as CFOTSXV:HLSHls Therapeutics
23/08/201800h08PR Newswire (Canada)HLS Therapeutics Announces Grant of Stock OptionsTSXV:HLSHls Therapeutics
15/08/201812h30PR Newswire (Canada)HLS Therapeutics Announces Q2 2018 Financial ResultsTSXV:HLSHls Therapeutics
30/07/201812h30PR Newswire (Canada)HLS Therapeutics to Host 2018 Second Quarter Results Conference CallTSXV:HLSHls Therapeutics
25/06/201812h30PR Newswire (Canada)HLS Therapeutics Reports Annual Meeting ResultsTSXV:HLSHls Therapeutics
15/06/201812h30PR Newswire (Canada)HLS Therapeutics to Host Annual Shareholder MeetingTSXV:HLSHls Therapeutics
30/05/201812h30PR Newswire (Canada)HLS Therapeutics Enters into Automatic Share Purchase PlanTSXV:HLSHls Therapeutics
16/05/201812h30PR Newswire (Canada)HLS Therapeutics Announces Q1 2018 Financial ResultsTSXV:HLSHls Therapeutics
09/05/201823h00PR Newswire (Canada)HLS Therapeutics Announces Normal Course Issuer BidTSXV:HLSHls Therapeutics
09/05/201812h30PR Newswire (Canada)HLS Therapeutics to Host 2018 First Quarter Results Conference CallTSXV:HLSHls Therapeutics
07/05/201812h30PR Newswire (Canada)HLS Appoints Ryan Lennox as General CounselTSXV:HLSHls Therapeutics
26/04/201812h30PR Newswire (Canada)HLS Therapeutics Announces Partial Redemption of Preferred SharesTSXV:HLSHls Therapeutics
20/04/201812h30PR Newswire (Canada)HLS to Present at the 2018 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:HLSHls Therapeutics
29/03/201812h30PR Newswire (Canada)HLS Therapeutics Announces Fiscal 2017 Financial ResultsTSXV:HLSHls Therapeutics
19/03/201821h00PR Newswire (Canada)HLS Therapeutics to Host 2017 Fourth Quarter and Year End Results Conference CallTSXV:HLSHls Therapeutics
16/03/201816h00PR Newswire (Canada)HLS Therapeutics Inc. Opens the MarketTSXV:HLSHls Therapeutics
13/03/201821h15PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - GPLY; HLSTSXV:HLSHls Therapeutics
13/03/201821h13PR Newswire (Canada)IIROC Trading Resumption - GPLY; HLSTSXV:HLSHls Therapeutics
12/03/201823h01PR Newswire (Canada)HLS Therapeutics Completes Merger with Automodular CorporationTSXV:HLSHls Therapeutics
06/10/201022h19Marketwired CanadaTSX Venture Exchange Daily Bulletins for October 6, 2010TSXV:HLSHls Therapeutics
14/05/201022h50Marketwired CanadaTSX Venture Exchange Daily Bulletins for May 14, 2010TSXV:HLSHls Therapeutics
10/05/201015h44Marketwired CanadaSouthern Hemisphere Mining Limited: New Jorc Resource and Progress Update Los Pumas Manganese Project, ChileTSXV:HLSHls Therapeutics
06/05/201013h02Marketwired CanadaEurocontrol Technics Inc.: Athlone Global Security Investee Company Awarded Singapore Israel Industrial Research and DevelopmentTSXV:HLSHls Therapeutics
 Showing the most relevant articles for your search:TSXV:HLS

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
TG
LHA
Deutsche Lufthansa
CCOM
US30
US 30
NYSE
MRK
Merck
DBI
TDXP
Tec DAX
CCOM
US500
US 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
TG
BAYN
Bayer
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
DBI
SDXP
SDAX
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten